erdafitinib /- cetrelimab in muc patients with fgfr alterations
Published 2 years ago • 106 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
1:47
thor: erdafitinib in metastatic urothelial cancer with fgfr alterations
-
5:14
erdafitinib demonstrates efficacy in intermediate-risk nmibc with fgfr alterations
-
1:04
thor: erdafitinib in advanced or metastatic urothelial cancer and fgfr alterations
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
3:26
blc2001: erdafitinib for muc
-
10:46
new treatment of non-muscle-invasive bladder cancer
-
4:31
living the best life possible with metastatic bladder cancer
-
8:07
long term outcome of enfortumab vedotin pembrolizumab in first line locally advanced or metast...
-
2:34
norse: erdafitinib and cetrelimab in urothelial carcinoma
-
6:09
erdafitinib (erda) or erda plus cetrelimab for patients with metastatic or locally advanced urot...
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
1:09
futibatinib plus pembrolizumab for the treatment of advanced or metastatic urothelial carcinoma
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
2:09
enfortumab vedotin for bladder cancer
-
1:59
how can we best sequence novel treatments in urothelial cancer?
-
1:47
the future role of erdafitinib in advanced urothelial carcinoma
-
1:22
key clinical trials in urothelial carcinoma at esmo 2021
-
3:02
discussion on trial investigating erdafitinib in patients with urothelial cancer